US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NYKODE THERAPEUTICS AS

0.3800

0.0000

Volume:- -

Turnover:- -

Market Cap:124.09M

PE:-7.12

High:0.3800

Open:0.3800

Low:0.3800

Close:0.3800

52wk High:0.3800

52wk Low:0.1558

Shares:326.55M

Float Shares:143.66M

Volume Ratio:1.50

T/O Rate:- -

Dividend:0.10

Dividend Rate:26.50%

EPS(TTM):-0.0534

EPS(LYR):-0.1189

ROE:-9.10%

ROA:-12.08%

PB:1.25

PE(LYR):-3.20

Loading ...

Overview Company News Filings

Company Profile

Company Name:

NYKODE THERAPEUTICS AS

Exchange:

PINK LIMITED

Establishment Date:

2006

Employees:

62

Office Location:

Oslo Research Park,Gaustadalleen 21,Oslo,Oslo,Norway

Website:

http://www.vaccibody.com

Zip Code:

0349

Phone:

Fax:

- -

Introduction:

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for COVID-19 T cell vaccine development; and research agreement with Regeneron. The company was formerly known as Vaccibody AS. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VACBF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VACBF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VACBF\",,,,,undefined,":{"symbol":"VACBF","market":"US","secType":"STK","nameCN":"NYKODE THERAPEUTICS AS","latestPrice":0.38,"timestamp":1771621200000,"preClose":0.38,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":143656728,"shares":326546444,"eps":-0.053399,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-20 16:00:00 EST Delay","open":0.38,"high":0.38,"low":0.38,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.053399,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":0,"adr":0,"exchange":"PINK LIMITED","adjPreClose":0.38,"volumeRatio":1.4968807483438498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VACBF\",,,,,undefined,":{"symbol":"VACBF","floatShares":143656728,"roa":"-12.08%","roe":"-9.10%","lyrEps":-0.118883,"volumeRatio":1.4968807483438498,"shares":326546444,"dividePrice":0.1007,"high":0.38,"amplitude":0,"preClose":0.38,"low":0.38,"week52Low":0.15575,"pbRate":"1.25","psRate":"16.89","week52High":0.38,"institutionHeld":0,"latestPrice":0.38,"eps":-0.053399,"divideRate":0.265,"volume":0,"delay":15,"ttmEps":-0.053399,"open":0.38,"prevYearClose":0.15575,"prevWeekClose":0.38,"prevMonthClose":0.31,"prevQuarterClose":0.1557,"fiveDayClose":0.38,"twentyDayClose":0.1557,"sixtyDayClose":0.188},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VACBF\",params:#limit:5,,,undefined,":[{"date":"2025-05-27","symbol":"VACBF","amount":1,"announcedDate":"2025-04-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-28","defaultRemindTime":1748352600000,"name":"NYKODE THERAPEUTICS AS","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-28","currency":"NOK","dateTimestamp":1748318400000,"payDate":"2025-06-12"},{"date":"2024-05-14","symbol":"VACBF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715673600000,"name":null,"time":"","dateTimestamp":1715659200000,"actualEps":null},{"market":"US","date":"2022-08-24","symbol":"VACBF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1661313600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2020-11-24","symbol":"VACBF","reason":null,"defaultRemindTime":1606228200000,"announcedDate":"2020-11-23","type":"delisting","dateTimestamp":1606194000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VACBF\",market:\"US\",,,undefined,":[{"executeDate":"2025-05-27","recordDate":"2025-05-28","paymentDate":"2025-06-12","value":1,"currency":"NOK"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VACBF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1770786000000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":61534042,"yearFounded":2006,"employeeNum":62,"address":"Oslo Research Park,Gaustadalleen 21,Oslo,Oslo,Norway","zipCode":"0349","officePhone":"47 22 95 81 93"},"stockCompanyDetail":{"websiteUrl":"http://www.vaccibody.com","description":"Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for COVID-19 T cell vaccine development; and research agreement with Regeneron. The company was formerly known as Vaccibody AS. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.","exchange":"PINK LIMITED","name":"NYKODE THERAPEUTICS AS","nameEN":"NYKODE THERAPEUTICS AS"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VACBF\",market:\"US\",,,undefined,":null}}